Company Profiles

driven by the PitchBook Platform

Aprecia Pharmaceuticals

Description

Developer of high dose pharmaceuticals to treat central nervous system disorders. The company engages in the development, manufacturing and marketing of fast melt pharmaceutical products via advanced three-dimensional printing which can be used to treat epilepsy and other central nervous system disorders

2003

Founded

PRIVATE

Status

51-200

Employees

Debt

Latest Deal Type

$20M

Latest Deal Amount

$157M

Total Amount Raised

Description

Developer of high dose pharmaceuticals to treat central nervous system disorders. The company engages in the development, manufacturing and marketing of fast melt pharmaceutical products via advanced three-dimensional printing which can be used to treat epilepsy and other central nervous system disorders

Website:

www.aprecia.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Delivery

Other Industries

Drug Discovery
Pharmaceuticals

Primary Office

2010 Cabot Boulevard West Suite F Langhorne, PA 19047United States +1 (513) 984-5000
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Aprecia Pharmaceuticals's full profile, request a free trial.

Aprecia Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Aprecia Pharmaceuticals Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Aprecia Pharmaceuticals Investors (6)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Alpha Capital PartnersPE/BuyoutMinority000 0000000 0000
Ben Franklin Technology Partners of Southeastern PennsylvaniaVenture CapitalMinority000 0000000 0000
Blue Chip VentureVenture CapitalMinority000 0000000 0000
Deerfield ManagementVenture CapitalMinority000 0000000 0000
Hercules CapitalGrowth/ExpansionMinority000 0000000 0000
Alpha Capital Partners PE/Buyout
Ben Franklin Technology Partners of Southeastern Pennsylvania Venture Capital
Blue Chip Venture Venture Capital
Deerfield Management Venture Capital
Hercules Capital Growth/Expansion

Aprecia Pharmaceuticals Executive Team (13)

NameTitleBoard
Seat
Contact
Info
Donald WetherholdChief Executive Officer
Donald MonkhousePresident
Michael RohlfsChief Financial Officer
Robert WillifordChief Operating Officer
Aymsley ToomerDirector, Marketing Projects
Donald Wetherhold Chief Executive Officer
Donald Monkhouse President
Michael Rohlfs Chief Financial Officer
Robert Williford Chief Operating Officer
Aymsley Toomer Director, Marketing Projects

Aprecia Pharmaceuticals Board Members (2)

NameRepresentingRoleSinceContact
Info
E. AringtonSelfChairman000 0000
Lawrence GlassmannSelfBoard Member000 0000
E. Arington Chairman Self
Lawrence Glassmann Board Member Self
Request full access to PitchBook